HEMO26 Aug 2020 11:27
Just a reminder of what we could have from an article back in November -
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said testing has demonstrated that its CDX antibody is potentially a life-saving treatment for sufferers of forms of blood cancer.
The biopharmaceuticals firm is developing the treatment alongside an unnamed "global pharmaceutical company", which it refers to as GlobalCo.
Work with the company has entered its second phase, Hemogenyx said.
Hemogenyx added: "Hemogenyx and GlobalCo remain optimistic as to the outcome of these tests based on results to date and look forward to providing further updates as the development work progresses."
Alongside its development work with the undisclosed firm, the company is researching CDX's effectiveness in treating acute myeloid leukemia, acute lymphoblastic leukemia and myelodysplastic syndromes.
Testing of humanised mice, rodents carrying human genes, demonstrated that the CDX product candidate could provide "life-saving treatments" against the three blood cancers.